Use of hormone replacement therapy among Danish nurses in 1993

被引:34
作者
Hundrup, YA
Obel, EB
Rasmussen, NK
Philip, J
机构
[1] Natl Publ Hlth Inst, DK-2100 Copenhagen, Denmark
[2] Danish Inst Hlth & Nursing Res, Copenhagen, Denmark
[3] Sygehuset Oresund, Helsingor, Denmark
[4] Univ Hosp, Rigshosp, Copenhagen, Denmark
关键词
duration of therapy; hormone replacement therapy; reasons affecting use of hormone replacement therapy; side effects;
D O I
10.1080/j.1600-0412.2000.079003194.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. To describe the prevalence of women using systemic hormone replacement therapy in various age groups. To identify their reasons for choosing or not choosing the therapy, reasons for discontinuing the treatment, the prevalence of side effects among current users, and to estimate the duration of treatment. Methods. The study is based on postal questionnaires sent to 23,000 female Danish nurses above the age of 44 years. Out of these 19,953 (86%) responded. The questionnaire gave information on age, use of hormone replacement therapy, use of oral contraceptives, family predisposition and diseases. Duration of hormone replacement therapy was calculated by Cox regression analysis. Chi square tests were used to evaluate differences and 5%, was used as the level of significance. Results. Overall, 6673 (33%) had ever used hormone replacement therapy. The prevalence was highest in the age group 55-59, where 29.3% were currently using hormones. The must cited reasons for choosing hormone replacement therapy were vasomotor symptoms (62%) and prevention of osteoporosis (44%). Among never users 43% had not experienced climacteric symptoms, 24% found the therapy unnatural, and 22% were afraid of side effects. It was estimated that 70%;, still were using hormones five years after the start of therapy, 57% after ten years, and 48% after fifteen years. Women with a family history of osteoporosis used hormones longer than women without this predisposition. Conclusions. One third of all the women had ever used hormone replacement therapy and more than half of ever users used the therapy for more than ten years.
引用
收藏
页码:194 / 201
页数:8
相关论文
共 31 条
[1]   Operations strategy and organizational performance: An empirical study [J].
Ahmed, NU ;
Montagno, RV ;
Firenze, RJ .
INTERNATIONAL JOURNAL OF OPERATIONS & PRODUCTION MANAGEMENT, 1996, 16 (05) :41-&
[2]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[3]   PREVALENCE AND DETERMINANTS OF ESTROGEN REPLACEMENT THERAPY IN ELDERLY WOMEN [J].
CAULEY, JA ;
CUMMINGS, SR ;
BLACK, DM ;
MASCIOLI, SR ;
SEELEY, DG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (05) :1438-1444
[4]  
CLAYTON D, 1993, STAT MODELS EPIDEMIO, P298
[5]   Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women [J].
Doren, M ;
Schneider, HPG .
MATURITAS, 1996, 25 (02) :99-105
[6]   COMPLIANCE WITH LONG-TERM ORAL HORMONAL REPLACEMENT THERAPY [J].
EIKEN, P ;
KOLTHOFF, N .
MATURITAS, 1995, 22 (02) :97-103
[7]   Effect of postmenopausal hormone therapy on body weight and waist and hip girths [J].
Espeland, MA ;
Stefanick, ML ;
KritzSilverstein, D ;
Fineberg, SE ;
Waclawiw, MA ;
James, MK ;
Greendale, GA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) :1549-1556
[8]  
GRAY LA, 1977, OBSTET GYNECOL, V49, P385
[9]   EVALUATION OF AN ESTROGEN, ANDROGEN, ESTROGEN-ANDROGEN COMBINATION, AND A PLACEBO IN THE TREATMENT OF THE MENOPAUSE [J].
GREENBLATT, RB ;
BARFIELD, WE ;
GARNER, JF ;
CALK, GL ;
HARROD, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY, 1950, 10 (12) :1547-1558
[10]  
GRIFFITHS F, 1995, BRIT J GEN PRACT, V45, P355